Pulse Biosciences Stock Performance
| PLSE Stock | USD 17.61 0.03 0.17% |
Pulse Biosciences has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of 1.34, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pulse Biosciences will likely underperform. Pulse Biosciences right now holds a risk of 5.27%. Please check Pulse Biosciences treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to decide if Pulse Biosciences will be following its historical price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Pulse Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Pulse Biosciences may actually be approaching a critical reversion point that can send shares even higher in February 2025. ...more
Actual Historical Performance (%)
One Day Return (0.17) | Five Day Return (3.19) | Year To Date Return (1.01) | Ten Year Return 322.3 | All Time Return 322.3 |
1 | Acquisition by Zanganeh Mahkam of 200000 shares of Pulse Biosciences at 15.65 subject to Rule 16b-3 | 11/05/2024 |
2 | Acquisition by Mitchell Levinson of 322 shares of Pulse Biosciences at 10.0 subject to Rule 16b-3 | 11/15/2024 |
3 | How to Take Advantage of moves in - Stock Traders Daily | 11/19/2024 |
4 | Acquisition by Robert Duggan of 6054 shares of Pulse Biosciences at 16.74 subject to Rule 16b-3 | 12/11/2024 |
5 | Top Key Executive Robert Duggan, Pulse Biosciences, Inc.s largest shareholder sees value of holdings go down 13 percent after recent drop | 12/12/2024 |
6 | Acquisition by Robert Duggan of 55256 shares of Pulse Biosciences at 17.18 subject to Rule 16b-3 | 12/13/2024 |
7 | Executive Co-Chairman of Pulse Biosciences Robert Duggan Buys More Stock | 12/16/2024 |
8 | Disposition of 24656 shares by Robert Duggan of Pulse Biosciences at 11.0 subject to Rule 16b-3 | 12/18/2024 |
9 | Pulse Biosciences Shares Gap Up Should You Buy | 12/24/2024 |
10 | Acquisition by Laviolette Paul A of 450000 shares of Pulse Biosciences at 18.43 subject to Rule 16b-3 | 01/08/2025 |
11 | Pulse Biosciences Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium | 01/13/2025 |
| Begin Period Cash Flow | 61.1 M |
Pulse |
Pulse Biosciences Relative Risk vs. Return Landscape
If you would invest 1,781 in Pulse Biosciences on October 20, 2024 and sell it today you would lose (20.00) from holding Pulse Biosciences or give up 1.12% of portfolio value over 90 days. Pulse Biosciences is currently generating 0.1181% in daily expected returns and assumes 5.2658% risk (volatility on return distribution) over the 90 days horizon. In different words, 46% of stocks are less volatile than Pulse, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Pulse Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pulse Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pulse Biosciences, and traders can use it to determine the average amount a Pulse Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0224
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | PLSE | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.27 actual daily | 46 54% of assets are more volatile |
Expected Return
| 0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Pulse Biosciences is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pulse Biosciences by adding it to a well-diversified portfolio.
Pulse Biosciences Fundamentals Growth
Pulse Stock prices reflect investors' perceptions of the future prospects and financial health of Pulse Biosciences, and Pulse Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pulse Stock performance.
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.38 | ||||
| Current Valuation | 1.01 B | ||||
| Shares Outstanding | 61.52 M | ||||
| Price To Earning | (22.54) X | ||||
| Price To Book | 13.71 X | ||||
| Price To Sales | 60.23 X | ||||
| Revenue | (9 K) | ||||
| Gross Profit | (550 K) | ||||
| EBITDA | (42.37 M) | ||||
| Net Income | (42.21 M) | ||||
| Cash And Equivalents | 14.8 M | ||||
| Cash Per Share | 0.40 X | ||||
| Total Debt | 9.14 M | ||||
| Debt To Equity | 0.45 % | ||||
| Current Ratio | 3.14 X | ||||
| Book Value Per Share | 1.29 X | ||||
| Cash Flow From Operations | (33.04 M) | ||||
| Earnings Per Share | (0.82) X | ||||
| Market Capitalization | 992.88 M | ||||
| Total Asset | 59.15 M | ||||
| Retained Earnings | (336.92 M) | ||||
| Working Capital | 38.62 M | ||||
| Current Asset | 4 M | ||||
| Current Liabilities | 660 K | ||||
About Pulse Biosciences Performance
By analyzing Pulse Biosciences' fundamental ratios, stakeholders can gain valuable insights into Pulse Biosciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pulse Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pulse Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 972.15 | 864.13 | |
| Return On Tangible Assets | (0.89) | (0.94) | |
| Return On Capital Employed | (0.96) | (1.00) | |
| Return On Assets | (0.82) | (0.86) | |
| Return On Equity | (0.86) | (0.81) |
Things to note about Pulse Biosciences performance evaluation
Checking the ongoing alerts about Pulse Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pulse Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pulse Biosciences had very high historical volatility over the last 90 days | |
| Net Loss for the year was (42.21 M) with loss before overhead, payroll, taxes, and interest of (550 K). | |
| Pulse Biosciences currently holds about 14.8 M in cash with (33.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4. | |
| Pulse Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 72.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from businesswire.com: Pulse Biosciences Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium |
- Analyzing Pulse Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pulse Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Pulse Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pulse Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pulse Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pulse Biosciences' stock. These opinions can provide insight into Pulse Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Pulse Stock analysis
When running Pulse Biosciences' price analysis, check to measure Pulse Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulse Biosciences is operating at the current time. Most of Pulse Biosciences' value examination focuses on studying past and present price action to predict the probability of Pulse Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulse Biosciences' price. Additionally, you may evaluate how the addition of Pulse Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |